Abstract:Evidence suggests that the glycogen synthase kinase 3 (GSK3)-dictated nuclear exclusion and degradation of Nrf2 is pivotal in switching off the self-protective antioxidant stress response after injury. Here, we examined the mechanisms underlying this regulation in glomerular disease. In primary podocytes, doxorubicin elicited cell death and actin cytoskeleton disorganization, concomitant with overactivation of GSK3 beta (the predominant GSK3 isoform expressed in glomerular podocytes) and minimal Nrf2 activation. SB216763, a highly selective small molecule inhibitor of GSK3, exerted a protective effect that depended on the potentiated Nrf2 antioxidant response, marked by increased Nrf2 expression and nuclear accumulation and augmented production of the Nrf2 target heme oxygenase-1. Ectopic expression of the kinase-dead mutant of GSK3 beta in cultured podocytes reinforced the doxorubicin-induced Nrf2 activation and prevented podocyte injury. Conversely, a constitutively active GSK3 beta mutant blunted the doxorubicin-induced Nrf2 response and exacerbated podocyte injury, which could be abolished by treatment with SB216763. In murine models of doxorubicin nephropathy or nephrotoxic serum nephritis, genetic targeting of GSK3 beta by doxycycline-inducible podocyte-specific knockout or pharmacologic targeting by SB216763 significantly attenuated albuminuria and ameliorated histologic signs of podocyte injury, including podocytopenia, loss of podocyte markers, podocyte de novo expression of desmin, and ultrastructural lesions of podocytopathy (such as foot process effacement). This beneficial outcome was likely attributable to an enhanced Nrf2 antioxidant response in glomerular podocytes because the selective Nrf2 antagonist trigonelline abolished the proteinuria-reducing and podocyte-protective effect. Collectively, our results suggest the GSK3 beta-regulated Nrf2 antioxidant response as a novel therapeutic target for protecting podocytes and treating proteinuric glomerulopathies.

Cdc42 deficiency induces podocyte apoptosis by inhibiting the Nwasp/stress fibers/YAP pathway

RhoA Deficiency Disrupts Podocyte Cytoskeleton and Induces Podocyte Apoptosis by Inhibiting YAP/dendrin Signal

Nmda Receptors Participate in the Progression of Diabetic Kidney Disease by Decreasing Cdc42-Gtp Activation in Podocytes

The β isoform of GSK3 mediates podocyte autonomous injury in proteinuric glomerulopathy.

Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis

Downregulation of CD2‐associated Protein Impaired the Physiological Functions of Podocytes

Calcineurin Inhibitors Ameliorate PAN‐induced Podocyte Injury Through the NFAT–Angptl4 Pathway

Genetic and Pharmacologic Targeting of Glycogen Synthase Kinase 3 Beta Reinforces the Nrf2 Antioxidant Defense Against Podocytopathy

KIBRA upregulation increases susceptibility to podocyte injury and glomerular disease progression

The Dysregulated Autophagy Signaling is Partially Responsible for Defective Podocyte Development in Wt1a Mutant Zebrafish

Regulation of CD2-associated Protein Influences Podocyte Endoplasmic Reticulum Stress-Mediated Apoptosis Induced by Albumin Overload

Down-regulation of Wt1 Activates Wnt/β-catenin Signaling Through Modulating Endocytic Route of LRP6 in Podocyte Dysfunction in Vitro.

Inhibiting calpain 1 and 2 in cyclin G associated kinase–knockout mice mitigates podocyte injury

The Activation of Extracellular Signal-Regulated Kinase is Responsible for Podocyte Injury

Podocyte Autophagic Activity Plays a Protective Role in Renal Injury and Delays the Progression of Podocytopathies.

Homocysteine Induces Podocyte Apoptosis by Regulating Mir‐1929‐5p Expression Through C‐myc, DNMT1 and EZH2

Yes-associated protein regulates podocyte cell cycle re-entry and dedifferentiation in adriamycin-induced nephropathy

CCDC92 promotes podocyte injury by regulating PA28α/ABCA1/cholesterol efflux axis in type 2 diabetic mice

Csk regulates angiotensin II-induced podocyte apoptosis

Inhibition Of Nephrin Activation By C-Mip Through Csk-Cbp-Fyn Axis Plays A Critical Role In Angiotensin Ii-Induced Podocyte Damage

Podocyte-specific deletion of ubiquitin carboxyl-terminal hydrolase L1 causes podocyte injury by inducing endoplasmic reticulum stress.